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Rey-Long Liu* and Chia-Chun ShihAbstract
Background: Curation of gene-disease associations published in literature should be based on careful and frequent
survey of the references that are highly related to specific gene-disease associations. Retrieval of the references is
thus essential for timely and complete curation.
Results: We present a technique CRFref (Conclusive, Rich, and Focused References) that, given a gene-disease
pair < g, d>, ranks high those biomedical references that are likely to provide conclusive, rich, and focused results
about g and d. Such references are expected to be highly related to the association between g and d. CRFref
ranks candidate references based on their scores. To estimate the score of a reference r, CRFref estimates and integrates
three measures: degree of conclusiveness, degree of richness, and degree of focus of r with respect to < g, d>. To evaluate
CRFref, experiments are conducted on over one hundred thousand references for over one thousand gene-disease
pairs. Experimental results show that CRFref performs significantly better than several typical types of baselines in
ranking high those references that expert curators select to develop the summaries for specific gene-disease associations.
Conclusion: CRFref is a good technique to rank high those references that are highly related to specific gene-disease
associations. It can be incorporated into existing search engines to prioritize biomedical references for curators and
researchers, as well as those text mining systems that aim at the study of gene-disease associations.
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of informationBackground
A gene is said to be associated with a disease if its certain
type of alteration is more frequent in people with the dis-
ease. For the purposes of disease diagnosis, prognosis, and
therapy, much research effort was devoted to identifying
gene-disease associations. A large amount of gene-disease
associations have been reported in biomedical literature
and search engines have been developed to retrieve the lit-
erature (e.g., medical genetics search services provided by
PubMeda). To facilitate knowledge sharing and further re-
search, the gene-disease associations reported in the litera-
ture need to be curated, and hence several online
databases of the gene-disease associations have been built
and maintained. Typical examples of such databases are
Genetic Home Reference (GHR)b and Online Mendelian
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unless otherwise stated.However, it is quite difficult to curate gene-disease asso-
ciations in a complete and timely manner, mainly due to
two reasons: (1) a huge and ever-growing amount of bio-
medical references need to be searched for the large num-
ber of possible gene-disease pairs, and (2) curation of even
a single gene-disease association needs to be based on a
careful survey of biomedical literature (e.g., for each asso-
ciation the curators of GHR need to carefully find and
check multiple articles to exclude unproven or controver-
sial informationd). Therefore, a large number of biomed-
ical experts are involved in the curation task (e.g.,
hundreds of experts in GHR review information for the
curatione), and the curators need to routinely spend much
effort maintaining the association database (e.g., OMIM
updates its database on a daily basisf, and GHR con-
ducts several updates in each weekg). New research find-
ings thus often take time to be curated from biomedical
literature [1-4].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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In this paper, we present a technique CRFref (Conclusive,
Rich, and Focused References) that, given a gene g and a
disease d, ranks high those biomedical references that are
likely to provide conclusive, rich, and focused results about
g and d. We believe that such references are highly related
to the association between g and d, and hence ranking
them high can help expert curators to curate gene-disease
associations in a more complete and timely manner.
Technically, candidate references are ranked based on
their scores. To estimate the score of a reference r, CRFref
estimates and integrates three measures: degree of focus,
degree of richness, and degree of conclusiveness of r with re-
spect to the given gene-disease pair < g, d>. Automatic esti-
mation and integration of the three measures are
challenging. The degree of conclusiveness is measured by
considering how g and d appear in the “concluding” parts
of r (i.e., title and ending part of r), which are those parts
that are more likely to convey the conclusion of r. If both g
and d tend to appear in the concluding parts, the conclu-
sion of r may be related to the association between g and d.
For the degree of richness, CRFref considers how r men-
tions different kinds of genes and diseases that are neither
g nor d. We expect that r might provide rich information
about < g, d > if there are many such genes and diseases in
r. Note that the expectation is reasonable only when r has
provided conclusive information about < g, d>, since in that
case the existence of the information about other genes
and diseases can indicate that the author of r has tried to
provide more information about < g, d > in r. Therefore, it
may be helpful to integrate the degree of conclusiveness
and the degree of richness. Finally, for the degree of focus,
CRFref considers how r provides conclusive information
about many genes and diseases that are neither g nor d. If r
does not provide such information, it should be focused
on < g, d > (i.e., the conclusive information of r is not di-
luted), and hence should have a larger score.
Related work
Prediction and extraction of gene-disease associations
Previous techniques that supported the analysis of gene-
disease associations often fell into two types: (1) those
that predict possible gene-disease associations, and (2)
those that extract the evidence about specific gene-
disease associations. The former aimed at suggesting
possible gene-disease associations for biomedical re-
searchers to explore and verify; while the latter aimed at
retrieving from biomedical references the evidence about
specific genes and diseases so that researchers can base
their new research on the current evidence that has been
found and published.
A survey of the prediction techniques can be found in
[5]. Typical resources employed by the prediction tech-
niques included chromosomal locations of the candidategenes [6], anatomical ontology [7], gene ontology [8],
protein-protein interaction networks (e.g., employed by
the GeneWanderer systemh), indirect but related evi-
dence about a gene g and a disease d reported in the lit-
erature [8], overlap of the index terms of references
related to g and d [9], co-occurrence of the concepts re-
lated to g and d in literature [4,6,10], published interac-
tions between g and those genes that are related to d [1],
and occurrence of g and d in overlapping clusters of lit-
erature [11]. Instead of predicting possible gene-disease
associations, CRFref aims at ranking high those biomed-
ical references that are highly related to specific gene-
disease pairs. The reference ranking task is to support
the analysis and curation of the associations that have
been reported in literature. From this point of view,
CRFref is related to those extraction techniques that ex-
tract information about genes and diseases in literature.
However, performance of the existing association ex-
traction techniques was often limited, even though vari-
ous language processing and learning techniques have
been developed. Some studies reported that precision of
the extraction was about 0.65 [2,12], and it was even
lower in some cases [1,3,13]. The improvement of the
precision rate was often at the cost of deteriorating the
recall rate [14]. The performance of the extraction sys-
tems may be even worse when the syntactic, semantic,
anaphoric, and discourse structures of the references are
beyond the scope of technical considerations of the sys-
tems. Therefore, although the extraction techniques are
still being refined (e.g., employing more association-
indicative terms in the extraction [15]), previous studies
have turned to focus on computer-aided curation so that
the quality of the curation can be promoted (e.g., manu-
ally confirming and enriching the associations between
biomedical entities [3]). CRFref is a technique to support
the computer-aided curation. Given highly related refer-
ences recommended by CRFref, curators can check and
extract gene-disease associations in the references, and
hence guarantee the quality of the curated gene-disease
associations. Reference recommendation is essential for
the curation of biomedical information [16], and it has
been a fundamental component in the systems that sup-
ports the curation (e.g., [17,18]). CRFref is the first sys-
tem that recommends those references that provide
conclusive, rich, and focused results about specific gene-
disease associations. It can contribute to the existing ex-
traction techniques as well. The extraction techniques
can extract gene-disease associations from the highly re-
lated references recommended by CRFref.
Text ranking technology
CRFref ranks references based on how they provide con-
clusive, rich, and focused results about specific gene-
disease pairs. Therefore, it is technically related to those
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and its application to biomedicine.
Since text ranking is an essential function of search en-
gines, previous information retrieval studies have devel-
oped many ranking techniques. Given a query, the rankers
assigned a score to each text, and the texts were ranked
based on the scores. Typical factors employed to estimate
the score of a text r included the frequency of each query
term appearing in r, the weight of the query term, and the
length of r (for a list of the ranking techniques, the reader
is referred to [19]). Therefore, r tends to have a larger
score if those query terms with higher weights appear fre-
quently in r. Machine learning approaches were also de-
veloped to integrate multiple rankers [20-24]. However,
the rankers did not consider the degrees of conclusiveness,
richness, and focus of r with respect to the query, which
consists of a gene and a disease. We will show that the de-
grees of conclusiveness, richness, and focus are particu-
larly useful in supporting the manual identification of
those references that are highly related to gene-disease
associations.
Proximity of query terms in the text was also employed
to improve the previous rankers, based on the expectation
that if query terms appear in a nearby area in a text r, the
score of r should be amplified as r is likely to be relevant
to the query [25-28]. Proximity of a gene and a disease in
a reference was also employed to extract the sentences
that provided the evidence about the association between
the gene and the disease [13]. We will show that CRFref
outperforms two state-of-the-art proximity-based tech-
niques in ranking high those references that biomedical
experts believe to be highly related to the associations be-
tween the genes and the diseases.
Positions and frequencies of terms in the references
were employed to identify relevant biomedical informa-
tion as well. To extract the information about the func-
tions of genes, information systems were developed to
extract text passages (e.g., sentences) from a given refer-
ence by selecting those passages that appear at certain
positions in the reference [29,30]. To automatically clas-
sify sentences in a reference into the categories about
evidence-based medicine (EBM), positions of the terms
in the reference were also shown to be good features for
the classifiers [31,32]. The goals of the previous studies
were thus different from that of CRFref, which aims at
identifying highly related references about gene-disease
associations, rather than extracting and classifying sen-
tences in the references. On the other hand, to identify
references about specific entities (chemicals, genes, or
diseases), previous systems often preferred those ab-
stracts in which the entities appeared frequently in
the abstracts [33,34], appeared at certain positions (e.g.,
the titles, the first sentences, and the last sentences of the
abstracts [33,34]), or co-occurred in a sentence [18,34].CRFref aims at identifying those references that expert cu-
rators select to develop the summaries for specific gene-
disease associations. Such references are highly related to
the gene-disease pairs, rather than simply about the gene-
disease pairs. Therefore, CRFref considers the degrees of
conclusiveness, richness, and focus of each reference, while
the previous systems did not simultaneously consider the
three degrees. We will show that CRFref performs signifi-
cantly better than a position- and frequency-based tech-
nique in identifying highly related references for over one
thousand gene-disease pairs.Methods
The research method of the paper consists of two
phases: the development phase and the evaluation phase
in which CRFref is developed and evaluated respectively.Development of CRFref
The input of CRFref includes a reference r, a gene-
disease pair < g, d>, and the thesauri of gene names and
disease names (with their synonyms). The output of
CRFref is the score of r with respect to < g, d>. CRFref is
developed to work on the title and the abstract of r (ra-
ther than the main text of r), as titles and abstracts of
references are publicly available and convey the main
idea of the references.
The thesauri of genes names and disease names are re-
quired, as the estimation of the degrees of conclusive-
ness, richness, and focus of r require the recognition of
g (and its aliases), d (and its aliases), and those genes
and diseases that are neither g nor d (as noted in Sec-
tion Problem definition and main contribution). To
setup the set of gene names, we employ the database
provided by HGNC (HUGO Gene Nomenclature Com-
mittee), which has comprehensively assigned symbols
(and names) to human genes [35]. All gene symbols and
names assigned by HGNC are downloaded from the
website of HGNCi. To setup the set of disease names,
we employ 2013 MeSH. As we are concerned with gen-
etic disorders, we employ all MeSH terms under the
MeSH tree nodes C04 to C26, but exclude ‘disease’, ‘syn-
drome’ and all terms under C01 (Bacterial Infections
and Mycoses), C02 (Virus Diseases), and C03 (Parasitic
Diseases) as they are not related to genetic disordersj.
We develop a set of numerical factors to estimate the
degrees of conclusiveness, richness, and focus. The
resulting design of the factors is presented in Section De-
velopment of CRFref. To integrate the factors, we em-
ploy RankingSVM [20], which is one of the best
techniques routinely used to integrate multiple factors
with SVM (Support Vector Machine) to achieve better
ranking (e.g., [23,25]). We employ SVMrank to imple-
ment RankingSVMk.
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Experiments are designed to empirically evaluate the con-
tributions of CRFref. We conduct comprehensive evalu-
ation on a broad coverage of diseases and genes. Table 1
summarizes main settings of the experiments, which are
described in the following subsections.
The data
A ranking technique can be used to support the curation
and analysis of new gene-disease associations reported in
literature if it can rank high those references that expert
curators have employed to edit the information about spe-
cific gene-disease associations. Therefore, in the experi-
ment we evaluate how CRFref (and several baseline
techniques) can rank high those references that curators
of GHR have employed to develop the summaries for
gene-disease associations. We thus consider all diseases
(and their aliases) listed in GHR as well as their associated
genes (and their aliases)l. For each gene-disease pair < g, d >
noted by GHR, candidate references are collected by
querying PubMed with the filter of ‘Medical Genetics’m.
The form of the query sent to PubMed is as follows:
Medical Genetics [Filter] AND (d and its aliases in
disjunctive form) AND (g and its aliases in disjunctive
form) AND (“0001”[Date - Publication] : “δ”[Date -
Publication])
In the query form, “0001” and “δ” are used to set the
range of the years of publication of the references (i.e.,
from year 0001 to year δ). We set δ to the year of publica-
tion of the most-recent reference that GHR curators
employed to develop a summary for < g, d>. By the query




(1) Gene-disease pairs and candidate references:
(A) Genes, diseases, and their aliases: All diseases (and th
aliases) are downloaded.
(B) Candidate references: Abstracts of references for eac
(C) Target gene-disease pairs: Target gene-disease pairs
(2) Target references of each target gene-disease pair:
For each target gene-disease pair, all candidate references
target references for the pair.
Baselines (1) Vector Space Model (VSM) and term weighting techniq
(2) Proximity-based techniques: Two techniques PRE and P
in the references;
(3) Position-and-frequency-based technique: A technique P
the frequencies of the disease and the gene in the referen
(4) Integrative techniques: Several rankers developed by co
Evaluation
criterion
(1) Mean Average Precision (MAP);
(2) Average Precision at top-X (average P@X), with X set toby GHR curators, although there are gene-disease pairs
(in GHR) for which references selected by GHR curators
cannot be retrieved by the queryn. We thus obtain 850,605
references pertaining to topics in medical genetics for
1,240 gene-disease pairs (for 664 diseases and 1,006
genes)o. For each gene-disease pair, we focus on the refer-
ences whose abstracts mention both the gene and the dis-
easep, because such references are likely to be about the
associations between the gene and the disease. We thus
totally have 101,899 such references, which serve as the
candidate references in the experiment.
For each gene-disease pair, GHR curators may select
some references that are about the gene or the disease
but not both. Therefore, not all references selected by
GHR for the gene-disease pair can be retrieved as candi-
date references, which need to mention both the gene
and the disease. Therefore, for each target gene-disease
pair, all candidate references that GHR curators employed
to develop a summary for the pair are the target refer-
ences for the pairq. We thus obtain 4,349 target references.
For each gene-disease pair that has target references, we
analyze the percentage of the target references in the list
of candidate references. Figure 1 shows that the per-
centage distributes diversely, which indicates that the
rankers have diverse degrees of difficulty in ranking the
target references high for the gene-disease pairs. All
terms in the references are normalized by replacing all
non-alpha-numeric characters with a space character
and replacing upper-case characters with lower-case
characters except for those terms that consist of upper-
case characters.
Since CRFref and the baseline techniques require
training data to build their rankers, we evenly split the
1,240 target gene-disease pairs into four parts. A 4-foldSetting
eir aliases) listed in GHR as well as their associated genes (and their
h of the gene-disease pairs are collected by querying PubMed.
are obtained from GHR.
that GHR curators employed to develop a summary for the pair are the
ues: Two techniques: Lucene and BM25;
LM that enhance BM25 with the proximity of the disease and the gene
osFreq that ranks candidate references by considering the positions and
ces;
mbining the above techniques with SVMrank.
1, 2, and 3.
Figure 1 Distribution of the percentage of target references for
each gene-disease pair: The percentage distributes diversely,
indicating that the rankers have diverse degrees of difficulty in
ranking the target references high for the gene-disease pairs.
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into four parts. In each experiment fold, a part of the data
is used for testing while the other three parts are used for
training. The cross-validation process is then repeated four
times, with each of the four parts used exactly once as the
testing data. We then report the average performance of
CRFref and each baseline, and conduct two significance
tests (the paired t-test and the Wilcoxon signed-rank test)
to verify whether the performance differences between
CRFref and the baselines are statistically significant. A per-
formance difference is statistically significant only if both
tests show that they are statistically significant.
Baseline techniques for performance comparison
To evaluate CRFref with respect to typical ranking tech-
niques, we implement four types of rankers as the base-
lines: (1) rankers based on Vector Space Model (VSM)
and term weighting techniques, (2) proximity-based
rankers, (3) position-and-frequency-based rankers, and
(4) integrative rankers that integrate multiple rankers.
All the rankers receive a candidate reference r and a
query q, which is a gene-disease pair < g, d > with aliases
of g treated as g and aliases of d treated as d. The
rankers return a score for r so that all the candidate ref-
erences are sorted based on their scores.
For the first type of baselines, we test two popular
rankers: Lucene and BM25. Lucene was often employed
in previous biomedical text retrieval and mining studies
(e.g., [33]). It estimates similarities between a query and
a document based on VSM, which is a popular tech-
nique to measure query-document similarity. We em-
ploy Apache Lucene 4.4 in the experimentr. On the
other hand, BM25 [36] was a popular baseline in many
previous studies as well [19]. It ranks a reference rhigher if r shares more highly-weighted terms with the
query q, with a special consideration on the mean length
of the references. More specifically, the BM25 score of r
with respect to q is measured by Equation 1.
BM25 r; qð Þ ¼
X
t∈r∩q
TF t; rð Þ k1 þ 1ð Þ






In Equation 1, N is the total number of training refer-
ences, n is the number of training references containing t
(either g or d in the given gene-disease pair), k1 = 2,
b = 0.75, |r| is the number of words in r (length of r),
avgrl is the average number of words in training refer-
ences (average length of training references), and TF is
the term frequency. Similar ideas of Lucene and BM25
have been employed by many search engines as well.
For the second type of baselines, we implement two
techniques that enhance BM25 by the proximity be-
tween genes and diseases in the references. The two
techniques are PRE (Proximity-based Ranker Enhancer
[25]) and PLM (Proximity Language Model, [27]). They
were shown to be two of the best proximity-based tech-
niques to enhance text rankers [25,27]. They are applied
to BM25 by adjusting the TF of the gene and the disease
(recall that BM25 has a TF factor, ref. Equation 1). Given
a reference r and a query q, both PRE and PLM assess
the term frequency (TF) of t (either g or d in the query)
in r, and expect that BM25 may be improved if it em-
ploys the adjusted TF. Both PRE and PLM assign a lar-
ger increment to TF of t if other terms in q appear at a
nearby area of t in r. The incremented TF helps BM25
to assign a larger score to r. For more detailed defini-
tions of PRE and PLM, the reader is referred to [25] and
[27], respectively.
For the third type of baselines, we implement a ranker
PosFreq based on the idea of eGRAB (Extractor of Gene-
Relevant ABstracts), which retrieved those abstracts in
which the gene appeared at the titles, the first sentences,
and the last sentences of the abstracts, as well as those ab-
stracts in which the gene appeared at least three times
[33]. Given a gene-disease pair < g, d > and a reference r,
PosFreq employs eight factors: (1) whether g appears in
the title of r, (2) whether d appears in the title of r, (3)
whether g appears at the first sentence of the abstract of r,
(4) whether d appears at the last sentence of the abstract
of r, (5) whether g appears at the last sentence of the ab-
stract of r, (6) whether d appears at the first sentence of
the abstract of r, (7) whether g appears at least three times
in the abstract of r, and (8) whether d appears at least
three times in the abstract of r. To integrate the eight fac-
tors, we employ RankingSVM, which is one of the best
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Section Development of CRFref ). PosFreq aims at
representing those techniques that retrieves refer-
ences based on both the positions and the frequen-
cies of biomedical entities in the references (as noted
in Section Text ranking technology).
For the fourth type of baselines, we create several inte-
grative rankers by combining the above baselines with
RankingSVM. By comparing the performance of CRFref
and the integrative rankers, we can evaluate CRFref
more comprehensively.Evaluation criteria
We employ mean average precision (MAP) and average
precision at top-x (average P@X) as two criteria to evalu-
ate the performance of each ranker. Both criteria were
commonly employed to evaluate text rankers. They aim at
measuring how highly related references are ranked higher
for the curators to read. A ranker that can achieve better
MAP and average P@X is thus expected to be more cap-
able of providing more references that deserve consider-
ation by the curators, even though the curators have not
selected the references. In practice, such rankers can be a
good tool for the curator to build the database of gene-














In Equation 2, |Q| is the number of gene-disease pairs,
and hence MAP is the average of the average precision
(AP) values for all gene-disease pairs. The AP value for
the ith gene-disease pair is defined in Equation 3, where
ki is the number of target references for the i
th gene-
disease pair, and Doci(j) is the number of references
whose ranks are higher than or equal to that of the jth
target reference for the ith gene-disease pair. If a ranker
can rank higher the target references (i.e., those that
have been employed by GHR curators to develop a sum-
mary for the gene-disease pair), the AP value for the pair
will be larger.
On the other hand, average P@X measures how each
ranker ranked the target references at the top-X posi-





P@X ið Þ ¼ ðFor pair i; number of top−X references
that are targetsÞ = X
ð5Þ
In Equation 4, |Q| is the number of gene-disease pairs,
and hence average P@X is the average of the P@X values
for all gene-disease pairs. The P@X value for the ith gene-
disease pair is defined in Equation 5, which measures the
precision rate when top-X references are seen by the
reader. By setting X to a small value, P@X can be used to
measure whether a ranker can rank target references very
high so that expert curators can focus on reading only a
small number of recommended references. We thus
report average P@X, with X set to 1, 2, and 3.
Result
Development of CRFref
Table 2 defines the thirteen factors that CRFref employs
to measure the degrees of conclusiveness (ref. the 1st to
the 7th factors), richness (ref. the 8th to the 9th factors),
and focus (ref. the 10th to the 13th factors) of a reference
r with respect to a gene-disease pair < g, d>. With the
aliases of genes and diseases noted in GHR, aliases of g
are treated as g, and aliases of d are treated as d. The
thirteen factors are integrated by RankingSVM (as noted
in Section Development of CRFref). In the 4-fold cross
validation experiments (ref. Section The data), training
data is used to train RankingSVM, which is then tested
with the test data.
The 1st to the 3rd factors are commonly employed by
text rankers. The 1st factor (Length) is the normalized
length of r (i.e., normalized number of words in r). The
normalization is conducted by employing the average
length (AvgLen) of the references in the training data so
that Length(r) is set to 1.0 if length of r is greater than
AvgLen. The factor is related to the “density” of g and d
in r (a smaller Length(r) tends to increase the density),
and hence is related to the degree of conclusiveness of r
with respect to < g, d>. The 2nd factor (GeneTF) and the
3rd factor (DiseaseTF) count the term frequencies of g
and d in r, respectively. They are related to the degree of
conclusiveness as well, since they indicate how r repeat-
edly mentions g and d. GeneTF and DiseaseTF are nor-
malized, and hence they are in the range of [0, 1].
The 4th to the 7th factors are more related to the
degree of conclusiveness. The 4th factor (Gene@Title)
and the 5th factor (Disease@Title) are concerned with
whether g and d appear in the title of r respectively. If g
and d appear in the title of r, we expect that r provides
Table 2 Given a reference r and a gene-disease pair < g, d>, CRFref estimates and integrates three measures: degrees
of conclusiveness, richness, and focus of r with respect to < g, d >
Factors Definition Type
(1) Length(r)








1 if TF g; rð Þ > 5 b½ 






1 if TF d; rð Þ > 5









1 if d appears in the title of r
0 otherwise

(6) Gene@Ending(g,r) LastPos g;rð Þ
c½ 
length of r
(7) Disease@Ending(d,r) LastPos d;rð Þlength of r
(8) NotGeneNum(g,r)
1 if G























(10) NotGene@Title(g,r) 1 if there is a gene g
0




(11) NotDisease@Title(d,r) 1 if there is a disease d
0
∈D− df g that appears in the title of r
0 otherwise










[a]AvgLen is the average length of references.
[b]TF(x,r): Term frequency of x in r.
[c]LastPos(x,r): The last position of x in r.
[d]G: Set of gene names in HUGO Gene Nomenclature Committee (HGNC).
[e]D: Set of terms in MeSH class of C04 to C26, with ‘disease’ and ‘syndrome’ removed.
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d. Another “concluding” part of r that might provide
conclusive results should be the ending part of r, as au-
thors of a reference tend to provide their research con-
clusions at the end of the reference. Therefore, the 6th
factor (Gene@Ending) and the 7th factor (Disease@End-
ing) transform the last position of g and d in r into a
score respectively. The score is normalized by the length
of r. It will be quite small if the last position is far from
the end of r.
The 8th factor (NotGeneNum) and the 9th factor (Not-
DiseaseNum) aim at measuring the degree of richness of
r with respect to < g, d>. NotGeneNum is concerned
with the number of distinct genes that are not g but ap-
pear in r. Similarly, NotDiseaseNum is concerned with
the number of distinct diseases that are not d but appearin r. Therefore the two factors consider whether r men-
tions several genes and diseases that are neither g nor d
but are related to g and d. In that case, r might provide
rich information about < g, d>, and hence its degree of
richness for < g, d >may be larger. As noted in Sec-
tion Development of CRFref, for the thesaurus of gene
names (i.e., the set G in Table 2) we employ the database
provided by HGNC, and for the thesaurus of disease
names (i.e., the set D in Table 2) we employ 2013 MeSH.
The 10th to the 13th factors aim at measuring the
degree of focus of r with respect to < g, d>. They are ac-
tually the counterparts of the 4th to the 7th factors re-
spectively − they are concerned with how r provides
conclusive results about those genes and diseases that
are neither g nor d. Therefore, the four factors are con-
cerned with whether such genes and diseases appear in
: Statistically significant differences with p 0.05
Figure 2 Comparing MAP of CRFref and each individual baseline: When CRFref only considered the degree of conclusiveness, it had
been able to perform significantly better than all baselines except for PosFreq, which had quite similar performance; When CRFref
considered conclusiveness, richness, and focus, it performed significantly better than all the baselines.
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factor NotDisease@Title) and the ending part (ref. the
12th factor NotGene@Ending and the 13th factor NotDi-
sease@Ending) of r. We expect that if r provides conclu-
sive results about such genes and diseases, r might not
focus on the association between g and d.
Evaluation of CRFref
CRFref and each individual baseline
Figure 2 compares MAP of CRFref and individual base-
lines, which include the first three types of rankers noted
in Section Baseline techniques for performance compari-
son (i.e., PosFeq, PRE, BM25, PLM, and Lucene). To verify
whether the performance differences were statistically sig-
nificant, we conducted two significance tests (the Wil-
coxon signed-rank test and the t-test) on the AP valuesFigure 3 Comparing average P@X of CRFref and each individual base
indicating that CRFref ranked highly related references very high so t
recommended references.for the 1,240 gene-disease pairs. A performance difference
was statistically significant only if both tests showed that
they were statistically significant. The results showed that
when CRFref only considered the degree of conclusiveness
(i.e., employing only the 1st to the 7th factors defined in
Table 2), it was able to perform significantly better than all
baselines except for PosFreq. The performance difference
between PosFreq and the “conclusiveness-only” version of
CRFref was not statistically significant. This result con-
firms that the degree of conclusiveness is a key concern
for expert curators to select biomedical references to de-
velop summaries for gene-disease associations. Term
proximity (mainly considered by PRE and PLM) and term
weights (mainly considered by BM25 and Lucene) are not
the key factors in identifying highly related references
about the gene-disease associations.: Statistically significant differences with p 0.05
line: CRFref performed significantly better than all the baselines,
hat expert curators can focus on reading only a small number of
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ness and richness (i.e., using the 1st to the 9th factors
defined in Table 2), it performed significantly better
than all the baselines, including PosFreq. This result
confirms the contribution of the degree of richness.
When CRFref considered conclusiveness, richness, and
focus (i.e., using all the 13 factors in Table 2), it per-
formed even better. This result confirms the contribu-
tion of the degree of focus, which helps to rank lower
those references that provide conclusive information
about many genes and diseases that are neither the tar-
get gene nor the target disease. The degree of focus is
actually an extension of the degree of conclusiveness,
and with the extension CRFref performs even better.
Figure 3 compares average P@X of CRFref and the
individual baselines. Similarly, to verify whether the
performance differences were statistically significant,
two significance tests were conducted on the P@X
values for the 1,240 gene-disease pairs. The results
showed that CRFref performed significantly better than
all the baselines, indicating that CRFref ranked highly
related references very high (top-3) so that expert cura-
tors can focus on reading only a small number of rec-
ommended references. With the better results in both
MAP and average P@X, CRFref is expected to be more
capable of providing more references that may deserve
consideration by the curators, even though the curators
have not selected the references (this may be a reason
why P@X for each gene-disease pair is not necessarily
high in the experiment).
We also analyzed the percentage of gene-disease pairs
for which P@X > 0. A higher percentage indicates that
the ranker can help expert curators to read a small
number of recommended references for more gene-
disease pairs. Table 3 shows the result. CRFref ranked
very high (top-3) the target references for over 53% of
the gene-disease pairs, while all the baselines did not
achieve the high percentage. The contribution is of
practical significance to curators, because there are
often a large number of gene-disease pairs, and each
pair often has a large number of candidate references
to be checked by the curators.Table 3 Percentage of gene-disease pairs for which P@X > 0: W
ranked highly related references at top-3 for a higher percen






Lucene 24.60%CRFref and the integrative baselines
We further investigated whether CRFref performed bet-
ter than the integrative baselines (i.e., the fourth type of
baselines noted in Section Baseline techniques for perform-
ance comparison), which were implemented by integrating
the above individual rankers with RankingSVM. Since Pos-
Freq was the best baseline, we integrated it with the other
four baselines PRE, BM25, PLM, and Lucene, and the
resulting integrative rankers were named PRE + PosFreq,
BM25 + PosFreq, PLM+PosFreq, and Lucene + PosFreq,
respectively.
Figure 4 compares MAP of CRFref and the integrative
rankers. The result indicated that the integration was often
helpful for the individual baselines. Most integrative
rankers (i.e., PRE + PosFreq, BM25 + PosFreq, and PLM+
PosFreq) performed better than PosFreq (ref. performance
of PosFreq shown in Figure 2 and performance of the inte-
grative rankers shown in Figure 4), indicating that PosFreq
benefited from the integration as well. Although some of
the integrative rankers performed better than “conclusive-
ness-only” version of CRFref, all the performance differ-
ences were not statistically significant. When CRFref
considered conclusiveness, richness, and focus, it per-
formed significantly better than all the integrative rankers.
This result reconfirms the contribution of CRFref.
We also implemented a ranker by integrating all the in-
dividual rankers (PRE, BM25, Lucene, and PosFreq) ex-
cept for PLM (since both PLM and PRE contributed term
proximity information, and the results shown in Figures 2
and 3 indicated that PRE performed better than PLM).
MAP of the ranker was 0.31671, which was lower than
the MAP of most integrative rankers. Therefore, integra-
tion of many baselines does not necessarily produce better
performance.
Figure 5 compares average P@X of CRFref and the inte-
grative rankers. Again, CRFref performed significantly bet-
ter than all the rankers, even though they were improved
by integration with PosFreq. Table 4 shows the percentage
of gene-disease pairs for which P@X> 0. Again, CRFref
achieved a higher percentage than all the integrative base-
lines. With the support provided by CRFref, expert curators
can check a small number of recommended references forhen compared with the individual baselines, CRFref
tage of gene-disease pairs







: Statistically significant differences with p 0.05
Figure 4 Comparing MAP of CRFref and each integrative baseline: Although each baseline was improved by integrating it with
PosFreq, CRFref performed significantly better than all the integrative baselines when it considered conclusiveness, richness,
and focus.
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bution of CRFref.
Integration of CRFref and the baselines
We are also interested in the possible contribution of inte-
grating CRFref and each of the individual baselines and
the integrative baselines. The integration was achieved by
RankingSVM as well. Table 5 compares MAP values of
CRFref and those baselines that were integrated with
CRFref. By the integration with CRFref, all individual base-
lines and integrative baselines were improved. However,
all the integrated versions did not perform significantly
better than CRFref, and CRFref even performed better
than some of them. For example, although CRFref +
Lucene performed much better than Lucene, it performed
significantly worse than CRFref. This result indicates
that CRFref has been a good ranker that can be usedFigure 5 Comparing average P@X of CRFref and each integrative bas
with PosFreq, CRFref performed significantly better than all the integindependently. Other kinds of factors concerning term
frequencies, term positions, term proximity, and term
weights are not necessarily helpful in improving CRFref.
Table 6 compares average P@X of CRFref and the inte-
grated versions. All baselines were improved by integrat-
ing them with CRFref. When compared with CRFref,
some of the integrated versions achieved better perform-
ance in P@3 but not P@1.
A case study
After showing that CRFref performed better than all the
baselines, we conducted a case study to further illustrate
the contribution of CRFref. The case study was about
the disease sickle cell disease. GHR experts noted that
sickle cell disease was associated with the gene beta-glo-
bin, which was associated with three disorders, including
sickle cell disease, beta-thalassemia, and beta-globin type: Statistically significant differences with p 0.05
eline: Although each baseline was improved by integrating it
rative baselines.
Table 4 Percentage of gene-disease pairs for which P@X > 0: When compared with the integrative baselines, CRFref
ranked highly related references at top-3 for a higher percentage of gene-disease pairs
Ranker % of pairs for which P@1 > 0 % of pairs for which P@2 > 0 % of pairs for which P@3 > 0
CRFref 34.44% 46.29% 53.55%
PRE + PosFreq 28.71% 41.85% 50.24%
BM25 + PosFreq 29.35% 41.77% 50.32%
PLM + PosFreq 28.23% 41.94% 48.47%
Lucene + PosFreq 26.85% 40.32% 47.98%
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ences to develop the summary for sickle cell diseaset.
The references were about the overview, the risk factor,
the outcome, and the therapy of sickle cell disease.
Among the 8 references, only one citation (PubMed ID:
10791557) was about sickle cell disease and beta-globin,
and hence was the target reference selected to develop the
summary for the association between sickle cell disease
and beta-globin. We were thus concerned with the cost of
identifying the target reference using PubMed, the best
baselines, and CRFref. The cost was an indicator to meas-
ure the contribution of CRFref to the curation of the asso-
ciation between sickle cell disease and beta-globin.
The query sent to PubMed was in the form noted in
Section The data, with the aliases of sickle cell disease
and beta-globin being added to the queryu. PubMed
returned 330 references. It employed the publication
date of each reference as a factor to rank the 330 refer-
encesv. Table 7 shows how the target reference and a
non-target reference (PubMed ID: 12972407) were
ranked by PubMed, CRFref, and the best baselines
(BM25 + PosFreq and PRE + PosFreq). We considered
the non-target reference because the two best baselines
ranked it at the top-1 position. PubMed and the base-
lines preferred the non-target reference to the targetTable 5 Comparing MAP of CRFref and the rankers
constructed by integrating the baselines and CRFref: All
baselines were improved by integrating them with
CRFref, however all the integrated versions did not
perform significantly better than CRFref
Type Ranker MAP
CRFref CRFref 0.34718
CRFref & individual baselines
CRFref + PosFreq 0.35046
CRFref + PRE 0.34447
CRFref + BM25 0.34855
CRFref + PLM 0.34630
CRFref + Lucene 0.34138s
CRFref & integrative baselines
CRFref + PRE + PosFreq 0.35010
CRFref + BM25 + PosFreq 0.35231
CRFref + PLM + PosFreq 0.34974
CRFref + Lucene + PosFreq 0.34639
s: Statistically significant differences with p ≤ 0.05one. It ranked the target reference at the 34th position,
indicating that for a curator that employed PubMed to
identify references to curate the association between
sickle cell disease and beta-globin, 33 references needed
to be read and checked, which would be a heavy burden
for the curator. CRFref ranked the target reference at
top-3, which should be helpful for the curator.
We further analyze the target reference and the non-
target reference. The target reference (excerpted) is as
follows:
PubMed ID: 10791557 (by Ashley-Koch A, Yang Q,
Olney RS, published in Am J Epidemiol.)
Title: Sickle hemoglobin (HbS) allele and sickle cell
disease: a HuGE review.
Abstract: Sickle cell disease is caused by a variant of the
beta-globin gene called sickle hemoglobin (Hb S). …
either two copies of Hb S or one copy of Hb S plus
another beta-globin variant (such as Hb C) are required
for disease expression. … individuals with sickle cell
disease exhibit significant morbidity and mortality.
Symptoms include chronic anemia, acute chest
syndrome, stroke, … Disease expression is variable and
is modified by several factors, the most influential being
genotype. Other factors include beta-globin cluster
haplotypes, alpha-globin gene number, and fetal
hemoglobin expression. … newborn screening,
better medical care, parent education, and penicillin
prophylaxis have successfully reduced morbidity and
mortality due to Hb S.
The target reference focuses on the disease (sickle cell
disease) and its association with the gene (beta-globin),
although the reference does not mention the gene and
the disease many times. CRFref successfully ranked the
reference at top-3, based on two reasons: (1) the gene
and the disease appear at the concluding parts of the ref-
erence (i.e., the title and the ending part), and (2) the
reference tends not to mention other genes and diseases
at the concluding parts. On the other hand, the non-
target reference (excerpted) is as follows:
PubMed ID: 12972407 (by Pritchard KA Jr, Ou J, Ou Z,
Shi Y, Franciosi JP, Signorino P, Kaul S, Ackland-
Table 6 Comparing average P@X of CRFref and the rankers constructed by integrating the baselines with CRFref: All
baselines were improved by integrating them with CRFref, however when compared with CRFref, some of the
integrated versions achieved better performance in P@3 but not P@1
Type Ranker P@1 P@2 P@3
CRFref CRFref 0.34435 0.30040 0.28078
CRFref & individual baselines
CRFref + PosFreq 0.33065 0.30202 0.28965
CRFref + PRE 0.32581s 0.30161 0.28777
CRFref + BM25 0.33548 0.30323 0.28938s
CRFref + PLM 0.33548 0.30242 0.28589
CRFref + Lucene 0.33306 0.29516 0.28132
CRFref & integrative baselines
CRFref + PRE + PosFreq 0.32258s 0.30685 0.29073s
CRFref + BM25 + PosFreq 0.33629 0.30887 0.29019
CRFref + PLM + PosFreq 0.32500s 0.30524 0.29341s
CRFref + Lucene + PosFreq 0.33468 0.30161 0.28159
s: Statistically significant differences with p ≤ 0.05
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http://www.biomedcentral.com/1471-2105/15/286Berglund C, Witte K, Holzhauer S, Mohandas N, Guice
KS, Oldham KT, Hillery CA., published in Am J Physiol
Lung Cell Mol Physiol.)
Title: Hypoxia-induced acute lung injury in murine
models of sickle cell disease.
Abstract: Vaso-occlusive events are the major source of
morbidity and mortality in sickle cell disease (SCD);
however, the pathogenic mechanisms driving these events
remain unclear. Using hypoxia to induce pulmonary
injury, we investigated mechanisms by which sickle
hemoglobin increases susceptibility to lung injury in a
murine model of SCD, where mice either exclusively
express the human alpha/sickle beta-globin (halphabetaS)
transgene (SCD mice) or are heterozygous for the normal
murine beta-globin gene and express the halphabetaS
transgene (mbeta+/-, halphabetaS+/-; heterozygote SCD
mice).… Hypoxia further decreased association of
HSP90 with eNOS in lungs of SCD and heterozygote
SCD mice, but not in the control lungs. … These data
support the hypotheses that hypoxia increases XO
release from ischemic tissues and that the local increase
in XO-induced oxidative stress can then inhibit HSP90
interactions with eNOS, decreasing *NO generation and
predisposing the lung to vaso-occlusion.
The non-target reference does not focus on the associ-
ation between the disease and the gene. It is about theTable 7 Two references ranked by PubMed, CRFref, and the b
ranked the target reference at top-3, while PubMed and the
Reference
PubMed
Target reference (PubMed ID: 10791557) 34th
Non-target reference (PubMed ID: 12972407) 13th
PubMed ranked the target reference at the 34th position, indicating that for an exp
association, 33 references needed to be read and checked, which was a burden forpathogenic mechanisms that drive vaso-occlusive prob-
lems in murine models of sickle cell disease. The reference
is preferred by PubMed and the best baselines, simply be-
cause of two reasons: (1) the gene and the disease appear
many times and are near to each other, and (2) the disease
appears at the title. CRFref successfully ranked the non-
target reference lower because several genes (e.g., XO and
eNOS) other than beta-globin appear in a concluding part
(i.e. end of the abstract) of the reference, making the refer-
ence less focused on the sickle cell disease and beta-globin.
Discussion
Application and suggestion
The results have shown that existing rankers, which rank
references by typical factors (i.e., term frequencies, term
weights, term proximity, and term positions), perform
significantly poorer than CRFref in identifying those ref-
erences that expert curators employ to develop summar-
ies for specific gene-disease associations. CRFref can
thus serve to identify highly related references for the
curation of gene-disease associations published in litera-
ture. Given a gene-disease pair, the curators can retrieve
candidate references by whatever ways (e.g., expanding
the queries by related terms) and constraints (e.g., limit-
ing the publication time of the references). CRFref can
then be used to prioritize the candidate references to
support more timely and complete curation. CRFref canest baselines (BM25 + PosFreq and PRE + PosFreq): CRFref
baselines preferred the non-target reference
Position
BM25 + PosFreq PRE + PosFreq CRFref
5th 6th 3rd
1st 1st 6th
ert that employed PubMed to identify references to curate the gene-disease
the expert.
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systems so that the systems can focus on highly related
references, and hence promotion of the quality of the
mining results may be expected.
Another interesting application of CRFref is the identifi-
cation of the highly related references about the interac-
tions and associations between different biomedical
entities, such as proteins, genes, chemicals, drugs, and dis-
eases. We expect CRFref may perform well in the applica-
tion since the main idea of CRFref is not limited to the
associations between genes and diseases. As biomedical
researchers are often concerned with the interactions and
associations between different entities, CRFref can help
the researchers by recommending highly related refer-
ences to them.
To implement the above applications, we suggest that
CRFref should be employed as a component in literature
search engines (e.g., PubMed). This is because the meas-
urement of conclusiveness, richness, and focus is helpful,
but it cannot be efficiently done to support online refer-
ence retrieval if the references in the database are not
pre-processed. The preprocessing should include the
identification of the locations of the biomedical entities
in the references. The preprocessed and cached location
information makes the search engines able to efficiently
measure conclusiveness, richness, and focus. The ideas
of CRFref should thus be incorporated into the archival
and ranking functions of the existing search engines so
that highly related references can be ranked higher for
the users online.
Limitation and future research
The data collection strategy has limitations. The candi-
date references for a gene-disease pair < g, d > are those
references that mention both g and d (and their
aliases). This way of data collection is reasonable, as
we aim at identifying highly-related references for < g,
d>. However, not all references retrieved by PubMed
can be candidate references (850,605 were retrieved by
PubMed but among which only 101,899 were candidate
references). This was because PubMed expanded and
relaxed the query to retrieve more references (e.g.,
expanding the query by related terms, and relaxing the
query by breaking a phrase into individual terms)s. We
expect that the references retrieved by a relaxed query
should tend to be not highly related to < g, d>. How-
ever, the effect of such references is not explored in the
paper.
Another limitation of our data collection strategy is
that for some gene-disease pairs in GHR, the references
selected by GHR experts cannot be retrieved by the
query noted in Section The data (there are 480 such
pairs, among the 1,720 pairs in GHR). Such pairs are ex-
cluded and hence they are not tested by the rankingsystems in the experiment, although all the ranking sys-
tems have worked on the same set of gene-disease pairs
(i.e., 1,240 pairs). To retrieve more references, the query
may be relaxed by removing some constraint (e.g., re-
moving the “medical genetics” filter) from the query or
incorporating more aliases of the gene and the disease in
the query.
CRFref has technical limitations as well, which de-
serve tackling in future research. Given a gene-disease
pair < g, d>, the degree of focus of a reference is based
on how the reference provides conclusive information
about the genes and the diseases that are neither g nor
d. To identify such genes and diseases, CRFref employs
thesauri of gene names and disease names. This way of
identification cannot properly deal with the common
cases where d might have several related but different
diseases or syndromes. For example, consider the target
reference discussed in the above case study. This refer-
ence focuses on the gene-disease pair < beta-globin,
sickle cell disease > but it also mentions several “symp-
toms” of the target disease ‘sickle cell disease’, such as
‘chronic anemia’, ‘acute chest syndrome’, and ‘stroke’,
which were identified as diseases by CRFref as well.
CRFref thus thinks the reference is less focused on the
target disease. Similar cases occur when several genes
that are related to the target gene happen to appear at
the concluding parts (i.e., title and ending part) of the
reference. Therefore, more intelligent identification of
the related genes and diseases can further refine the
measurement of the degree of focus. The related genes
and diseases may be recognized and excluded by ana-
lyzing the semantics of the sentences (e.g., by parsing)
and/or checking the relationships noted in a biomedical
thesaurus.
Another limitation of CRFref is incurred by the use of
term positions to measure the degrees of conclusiveness
and focus. To measure how a reference r provides conclu-
sive information about the target gene-disease pair < g, d>,
the 6th factor (Gene@Ending) and the 7th factor (Disea-
se@Ending) measure how g and d appear in the ending
part of the abstract of r. Similarly, to measure how r pro-
vides focused information about < g, d>, the 12th factor
(NotGene@Ending) and the 13th factor (NotDisease@End-
ing) measure how genes and disease other than g and d
appear in the ending part of the abstract of r. Although
the ending part is likely to be about the conclusion of r,
the precise position of the conclusion is hard to identify if
the abstract is not structured with explicit labels for the
conclusion. Therefore, more intelligent identification of
the concluding paragraph of a reference is an interesting
research problem. Previous techniques that extracted and
classified passages (e.g., [37]) may be applicable to the
problem. Integration of CRFref and the previous tech-
niques should be helpful in improving CRFref.
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Curation of gene-disease associations published in litera-
ture is essential for biomedical research. However, timely
and complete curation is both costly and challenging,
since the curation needs to be based on careful and fre-
quent survey of the references that are highly related to
specific gene-disease associations. Retrieval of the refer-
ences is thus essential for the curation.
We develop a technique CRFref that, given a gene-
disease pair < g, d>, ranks biomedical references based on
how they provide conclusive, rich, and focused results on
the associations between g and d. When identifying the
references that expert curators believed to be highly re-
lated to specific gene-disease pairs, CRFref performs sig-
nificantly better than typical types of rankers, which often
ranked references based on the weights, proximity, fre-
quencies, and positions of terms. CRFref can thus be in-
corporated into search engines to prioritize the highly
related references to support more timely and complete











hGeneWanderer is available at http://compbio.charite.
de/genewanderer/GeneWanderer.
i117,934 terms were downloaded in July 2013, through
http://www.genenames.org/cgi-bin/hgnc_downloads.
j45,383 terms were downloaded from 2013 MeSH,
which is available at http://www.nlm.nih.gov/mesh/filelist.
html.
kSVMrank is available at http://www.cs.cornell.edu/
People/tj/svm_light/svm_rank.html.
l1,720 gene-disease pairs (for 747 diseases and 1,327
genes) were downloaded in November 2012.
mThe filter of Medical Genetics aims at retrieving ref-
erences pertaining to topics in medical genetics (avail-
able at http://www.ncbi.nlm.nih.gov/pubmed/clinical).
nThere are 480 pairs (among the 1,720 pairs in GHR)
for which references selected by GHR curators cannot
be retrieved.
oThe medical genetics references were retrieved in 11/
21 ~ 11/25, 2012, with 100,000 as the maximum number
of references returned by PubMed for each query.
pFor each gene-disease pair, Lucene (available at http://
lucene.apache.org) was employed to remove those refer-
ences that did not mention both the gene and the disease.The removal is reasonable, as we aim at identifying
highly-related references for the gene-disease pair (ref. the
discussion in Section Limitation and future research).
qAmong the 1,240 gene-disease pairs, 109 pairs have
no target references. This is because for each of the 109
pairs, the references selected by GHR curators are not
listed in the candidate references, which need to mention
both the gene and the disease. To reduce the amount of
such pairs, the existence of a gene and a disease in a refer-
ence should be checked by intelligent named entity recog-
nition (rather than strict term matching by Lucene). In
the experiment, all the ranking systems work on the 109
pairs as well, because in practice the ranking systems often
need to work on those pairs that are not correlated (i.e.,
have no target references).
rLucene is available at http://lucene.apache.org, and its
technique to estimate query-document similarity is out-
lined at http://lucene.apache.org/core/4_4_0/core/org/
apache/lucene/search/similarities/TFIDFSimilarity.html.
sThe query expansion and relaxing strategies of PubMed
can be found at http://www.ncbi.nlm.nih.gov/books/
NBK3827/#pubmedhelp.I1_MeSH_translation_.
tThe list of references that GHR selected to develop the
summary for ‘sickle cell disease’ can be found in http://ghr.
nlm.nih.gov/condition/sickle-cell-disease/show/References.
uThe query sent to PubMed was in the form noted in
Section The data, with the publication date being set to
from year 0001 to year 2005 (since the most recent ref-
erence selected for “sickle cell disease” was published in
2005).
vThe references were sorted by PubMed relevance sort,
which considered the frequency and the position of search
terms in each reference (as done by the baselines), as well
as the publication date of each reference (ref. http://www.
nlm.nih.gov/pubs/techbull/so13/so13_pm_relevance.html).
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